All in 1 subscription.
Losing weight could now be easier than ever. Matthew Schneier discusses the rise of Ozempic, a diabetes drug moonlighting as an off-label appetite suppressant.
Bloomberg
Jun 1, 2023 - 7 min
The Wall Street Journal
Aug 19, 2023 - 10 min
The Atlantic
Jan 1, 2024 - 20 min
Jun 1, 2023 - 5 min
WIRED
Feb 5, 2023 - 12 min
MIT Technology Review
Apr 8, 2023 - 34 min